Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silodosin in Adult Women With Voiding Dysfunction
NCT07822113Phase 2Not yet recruiting
- Sponsor
- Jaber Al-Ahmad Al-Sabah Hospital
- Start
- Oct 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
A Phase 2 trial of silodosin in Voiding dysfunction, sponsored by Jaber Al-Ahmad Al-Sabah Hospital. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
silodosin
03
Conditions
Voiding dysfunction
Beyond the preview
Go deeper on NCT07822113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07822113.